Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Declines By 59.8%Ticker Report • about 1 month ago
Clearmind Medicine Inc. (NASDAQ:CMND Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 92,700 shares, a decline of...
Share to Feed
TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) ( Clearmind or the company ), a biotech company focused on discovery and development of...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq...
Clearmind Medicine (NASDAQ:CMND Get Free Report) and ABVC BioPharma (NASDAQ:ABVC Get Free Report) are both small-cap medical companies, but which is the better investment? We will...
TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
TEL AVIV, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Clearmind Medicine receives Patent Approval in China for treatment of binge behaviours...